Characteristics of Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Switching First-Line Therapies for Different Reasons

被引：0
|
作者：
Teter, Barbara [1 ]
Agashivala, Neetu [2 ]
Hashmonay, Ron [2 ]
Weinstock-Guttman, Bianca [1 ]
机构：
[1] SUNY Buffalo, Jacobs Neurol Inst, Buffalo, NY 14260 USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P01212
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Improved clinical outcomes for relapsing remitting multiple sclerosis (RRMS) patients treated with first line natalizumab vs first line injectable therapies
    Acosta, Carlos
    Jomaa, Khalil
    Su, Ray
    Jones, Eddie
    Husbands, Joseph
    Pike, James
    Berry, Mia
    NEUROLOGY, 2020, 94 (15)
  • [22] ADHERENCE AND PERSISTENCE AMONG PATIENTS TREATED WITH FIRST-LINE THERAPIES FOR RELAPSING -REMITTING MULTIPLE SCLEROSIS IN BRAZIL
    Guiart, A.
    Teich, V
    Oliveira, R.
    Amarante, D.
    Alves, J.
    Machado, M.
    VALUE IN HEALTH, 2015, 18 (07) : A879 - A879
  • [23] Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis
    Gajofatto, A.
    Bacchetti, P.
    Grimes, B.
    High, A.
    Waubant, E.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (01) : 50 - 58
  • [24] Monitoring cognition in relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients
    White, J.
    Gabriele, S.
    Lin, D.
    Vindici, J.
    Teoh, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 214 - 214
  • [25] Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosis
    Koch, Marcus W.
    Mostert, Jop
    Repovic, Pavle
    Bowen, James D.
    Wolinsky, Jerry S.
    Lublin, Fred D.
    Strijbis, Eva
    Cutter, Gary
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (04) : 1106 - 1116
  • [26] REGIONAL EFFICACY OF NATALIZUMAB TREATMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
    Doshi, Anisha
    Voysey, Zanna
    Bunting, Eva
    Malik, Muzaffar
    Rashid, Waqar
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [27] Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS)
    Mashayekhi, Farhad
    Hadipour, Elham
    Shabani, Somayeh
    Salehi, Zivar
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 237
  • [28] Depression in early relapsing-remitting Multiple Sclerosis (RRMS) patients with higher risk of progression
    Cihelkova, S.
    Baranikova, Z.
    Jung, M.
    Bojar, M.
    JOURNAL OF NEUROLOGY, 2010, 257 : S189 - S190
  • [29] Fatigue, cognition and personality in patients with relapsing-remitting multiple sclerosis (RRMS) - A longitudinal study
    Lang, C.
    Lang, M.
    Flachenecker, P.
    Meissner, H.
    Freidel, M.
    Herbst, H.
    Scholz, E.
    Hofmann, W.
    Schlegel, E.
    Elias, W.
    Gehring, K.
    Eckhardt, U.
    Bergmann, A.
    Reifschneider, G.
    Ries, S.
    Ring, C.
    Schreiber, H.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S179 - S179
  • [30] Relationship of natalizumab exposure and MRI response in patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
    Muralidharan, K. Kandadi
    Steiner, D.
    Elkins, J.
    Ho, P. -R.
    Amarante, D.
    Koendgen, H.
    Evans, K.
    Mikol, D.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 811 - 811
12345